Recent HIV/AIDS News from CDC, FDA, and NIAID
- June 12, 2013: Study Finds First Evidence That PrEP Can Reduce HIV Risk Among People Who Inject Drugs
“A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took the medication most consistently had even higher levels of protection, according to a new study announced today by the Centers for Disease Control and Prevention – in collaboration with the Bangkok Metropolitan Administration (BMA) and the Thailand Ministry of Public Health (MOPH).
"This is the first evidence that pre-exposure prophylaxis (PrEP) offers significant protection to individuals exposed to HIV through injection drug use. The findings were published online today in the Lancet.”
Read the CDC press release, fact sheet, and interim guidance.
- June 5, 2013: New Guidance for Industry Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment
“The Food and Drug Administration recently published new Guidance for Industry Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment
“The new guidance provides recommendations for the development of antiretroviral drugs regulated within the FDA's Center for Drug Evaluation and Research (CDER) for the treatment of human immunodeficiency virus-1 (HIV-1 or HIV) infection. Specifically, this guidance addresses the overall development program and clinical trial designs for antiretroviral drugs to support an indication for the treatment of HIV-1 infection.”
Read the FDA press release.
- June 5, 2013: NIH Scientists Discover How HIV Kills Immune Cells
“Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reveals how HIV triggers a signal telling an infected immune cell to die. This finding has implications for preserving the immune systems of HIV-infected individuals.”
Read the NIAID press release.
National Library of Medicine HIV/AIDS Community Information Outreach Project 2013 RFQ Posted
The National Library of Medicine (NLM) is pleased to announce the solicitation of quotations from organizations and libraries to design and conduct projects that will improve access to HIV/AIDS-related health information for patients, the affected community, and their caregivers.
Projects must involve one or more of the following information access categories:
- Information retrieval;
- Skills development;
- Resource development; and/or
- Equipment acquisition.
Emphasis is placed upon the following types of organizations or arrangements for developing these programs:
- Community-based organizations (CBOs) or patient advocacy groups currently providing HIV/AIDS-related services to the affected community;
- Public libraries serving communities in the provision of HIV/AIDS-related information and resources;
- Health departments or other local, municipal, or state agencies working to improve public health;
- Faith-based organizations currently providing HIV/AIDS-related services; and/or
- Multi-type consortia of the above-listed organizations that may be in existence or formed specifically for this project.
Awards are offered for up to $40,000.
Quotations are due to NLM on Thursday, July 18, 2013.
View the request for quotations (RFQ) for the HIV/AIDS Community Information Outreach Project 2013 on the Federal Business Opportunities website. Small businesses can apply to a specific set-aside.